SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001479290-24-000041
Filing Date
2024-02-29
Accepted
2024-02-28 18:32:46
Documents
4
Effectiveness Date
2024-02-29

Document Format Files

Seq Description Document Type Size
1 S-8 rvncs-8evergreen2024.htm S-8 94075
2 EX-FILING FEES exhibit107_calculationoffi.htm EX-FILING FEES 19665
3 EX-5.1 exhibit_51opinionofhonigma.htm EX-5.1 8771
4 EX-23.1 exhibit_231xpwcconsentxrvn.htm EX-23.1 2232
  Complete submission text file 0001479290-24-000041.txt   125813
Mailing Address 1222 DEMONBREUN STREET SUITE 2000 NASHVILLE TN 37203
Business Address 1222 DEMONBREUN STREET SUITE 2000 NASHVILLE TN 37203 6157247755
Revance Therapeutics, Inc. (Filer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-277490 | Film No.: 24697832
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)